Joseph, A.; Nyambura, C.W.; Bondurant, D.; Corry, K.; Beebout, D.; Wood, T.R.; Pfaendtner, J.; Nance, E.
Formulation and Efficacy of Catalase-Loaded Nanoparticles for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy. Pharmaceutics 2021, 13, 1131.
https://doi.org/10.3390/pharmaceutics13081131
AMA Style
Joseph A, Nyambura CW, Bondurant D, Corry K, Beebout D, Wood TR, Pfaendtner J, Nance E.
Formulation and Efficacy of Catalase-Loaded Nanoparticles for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy. Pharmaceutics. 2021; 13(8):1131.
https://doi.org/10.3390/pharmaceutics13081131
Chicago/Turabian Style
Joseph, Andrea, Chris W. Nyambura, Danielle Bondurant, Kylie Corry, Denise Beebout, Thomas R. Wood, Jim Pfaendtner, and Elizabeth Nance.
2021. "Formulation and Efficacy of Catalase-Loaded Nanoparticles for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy" Pharmaceutics 13, no. 8: 1131.
https://doi.org/10.3390/pharmaceutics13081131
APA Style
Joseph, A., Nyambura, C. W., Bondurant, D., Corry, K., Beebout, D., Wood, T. R., Pfaendtner, J., & Nance, E.
(2021). Formulation and Efficacy of Catalase-Loaded Nanoparticles for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy. Pharmaceutics, 13(8), 1131.
https://doi.org/10.3390/pharmaceutics13081131